Vast opportunities exist in growing cannabis space CannAssist is committed to establishing aggressive marketing presence in promising market CannAssist brings impressive advancements, achievements to the table, including its propriety CiBiDinol technology Carefully developing and executing a strategic go-to-market plan has never been more important for companies operating in the cannabis industry, according to a recent … Continue reading “CannAssist International Corp. (CNSC) Focused on Leveraging Position in Growing Cannabis Industry through Strategic Marketing Plan”
CannAssist (OTCQB: CNSC), a biotechnological pharmaceutical and wellness company, believes that its proprietary CiBiDinol technology will be a game-changer. According to a recent article, “the company believes that the amount of CBD needed to achieve the targeted therapeutic effects can be reduced significantly, resulting in reduced costs for both manufacturers and consumers.” CBD-based products “reduce … Continue reading “CBDNewsBreaks – CannAssist International Corporation (CNSC) Pioneers Promising CiBiDinol Technology”
Absorption vital component of product effectiveness CNSC’s proprietary CiBiDinol technology is cannabidiol made water compatible Xceptol products offer CBD in format more in line with body’s natural bioactivity CannAssist International (OTCQB: CNSC) is a biotechnological pharmaceutical and wellness company marketing its exclusive Xceptol consumer brand. The company is the owner of Xceptor Labs, which uses … Continue reading “CannAssist International Corp. (CNSC) Proprietary Tech Is Core of CBD Products with Better Absorption”
CannAssist (OTCQB: CNSC), a biotechnological pharmaceutical and wellness company, rapidly garnered a reputation and loyal following due to its innovative technology and proprietary product line, marketed through its Xceptol consumer brand. The company was founded in May 2017 and moved to the forefront of the cannabidiol industry following the passing of the 2018 Farm Bill, … Continue reading “CBDNewsBreaks – CannAssist International Corporation (CNSC) Leverages Proprietary Technology to Stand Distinct in Surging Market”
CBD products in oil-based form have compromised bioavailability, according to experts CNSC’s Xceptol CBD products created with proprietary CiBiDinol technology that addresses absorption issues for superior efficacy Third-party Xceptol testing shows 300% increased gut absorption, 400% increased skin penetration when compared to mainstream CBD oil products Growing in popularity in a myriad of markets, cannabidiol … Continue reading “CannAssist International Corp. (CNSC) Addresses CBD Absorption Issues with Proprietary CiBiDinol Technology”
Global cannabidiol market expected to increase almost sixfold by 2025 CNSC offers powerful line of CBD products under Xceptol brand CannAssist has forecast first-year sales of $5 million, with steady sales growth moving forward With industry experts predicting the stabilization of hemp prices and a more predictable market in 2021 (https://cnw.fm/7p6Dt), CannAssist International (OTCQB: CNSC) appears … Continue reading “CannAssist International Corp. (CNSC) Strengthens Position in Growing Sector with Exclusive Technology, Proprietary Line of CBD Products”
Imperial College of London review suggests that cannabis-based medicinal products offer significant relief from intractable epilepsy CNSC produces proprietary CBD products under the Xceptol brand that are created with branded Technology CiBiDinol that increases absorbability, bioavailability, shelf life Third-party Xceptol testing shows 300% increased gut absorption, 400% increased skin penetration when compared to mainstream CBD … Continue reading “CannAssist International Corp.’s (CNSC) Proprietary Technology Offers Superior Absorption, Efficacy”
Acceptance of Xceptol products on RangeMe website new revenue source, increasing SKUs and access to retailers RangeMe enables retail buyers to discover innovative, emerging products; empowers suppliers to manage, grow their brands CannAssist developed Xceptol brand to offer effective health and wellness solutions without side effects CannAssist International (OTCQB: CNSC) has announced that its flagship … Continue reading “CannAssist International Corp. (CNSC) Flagship Brand Approved, Included by Powerful Online Platform”
Market for CBD-based pain relief products is growing rapidly, projected to reach $20 billion by 2024 CNSC is a biotech company that produces fast-acting CBD products under the Xceptol brand Xceptol products are formulated with exclusive technology that increases absorbability, bioavailability, shelf life Third-party testing on Xceptol suggests 400% increase in skin penetration, 300% increase … Continue reading “CannAssist International Corp.’s (CNSC) Proprietary CiBiDinol Technology Promises to Outperform Conventional CBD Oil for Superior Pain-Relief”
CNSC partners with InvestorBrandNetwork to maximize communication, refine messaging and outreach. CannAssist focused on marketing Xceptol consumer brand, which provides products featuring proprietary CiBiDinol technology. IBN brings 15-plus years of experience assisting more than 500 client partners improve communications within investment community. Recognizing the critical nature of communications to the success of a business, CannAssist International (OTCQB: … Continue reading “CannAssist International Corp. (CNSC) Engages Communications Industry Leader IBN to Share Story, Reach Millions”
